Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

No clear link between pilonidal sinus disease and polycystic ovary syndrome was found.

Childhood growth hormone deficiency can be accurately diagnosed using gene expression data and random forest analysis.

The treatment showed promising hair regrowth in advanced-stage hair loss.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Gray hair regained color after thyroid hormone treatment.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Wildebeest stress and hormone levels are influenced by food availability, human presence, and reproductive cycles.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Substance from human umbilical cord blood cells promotes hair growth.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Lower SHBG levels may increase the risk of PCOS.